A comparative clinical study of ayurvedic and modern drug in DM type 2

Not Applicable

• Conditions: Health Condition 1: E119- Type 2 diabetes mellitus without complications

• Registration Number: CTRI/2020/02/023118
• Lead Sponsor: deepika dwivedi

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 24 November 2021

Recruitment & Eligibility

• Status: ot Yet Recruiting
• Sex: Not specified
• Target Recruitment: 0

Inclusion Criteria

1.Fasting blood sugar >= 126 mg/dl and up to 200 mg/dl.

2.Postprandial blood >= 200 mg/dl and up to 350 mg/dl.

Exclusion Criteria

1.Patients in <30 years and >60 years age group.

2.Patients of IDDM or juvenile onset diabetes.

3.Patients of Type-2DM with severe grade blood glucose levels (fasting >200 mg/dl and PP >350 mg/dl)

4.Patients of severe Diabetic complications such as cardiopathy, nephropathy, foot Gangrene etc and other endocrine disorders.

5.Pregnant and Lactating Mothers.

6.History of recurrent infections.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
The selected drug may interfere in the basic mechanism of glycemic control, regulate dyslipidemia etc. The selected drug may interfere in the mechanism of oxidative stress and the expression levels of selected genes in Type 2 DM and it help to explore the mechanism of action. <br/ ><br>Timepoint: 3 months <br/ ><br>

Secondary Outcome Measures

Name	Time	Method
The present study may be providing a lead to the researchers working in the area of traditional diabetes drug development.Timepoint: 3 months